Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Powell

Showing results (771-780 of 817) with videos related to

Pageof 82
Sort By:
The Journal of Clinical Investigation|April 24, 2020
Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cellsMin-Hee Oh, Im-Hong Sun, Liang Zhao, et al.
Nature|July 27, 2018
Functional aspects of meningeal lymphatics in ageing and Alzheimer's diseaseSandro Da Mesquita, Antoine Louveau, Andrea Vaccari, et al.
Nature|November 7, 2018
Publisher Correction: Functional aspects of meningeal lymphatics in ageing and Alzheimer's diseaseSandro Da Mesquita, Antoine Louveau, Andrea Vaccari, et al.
Nature|September 16, 2021
An engineered IL-2 partial agonist promotes CD8<sup>+</sup> T cell stemnessFei Mo, Zhiya Yu, Peng Li, et al.
Oncotarget|June 12, 2020
An exploratory study of metformin with or without rapamycin as maintenance therapy after induction chemotherapy in patients with metastatic pancreatic adenocarcinomaKatherine M Bever, Erkut H Borazanci, Elizabeth A Thompson, et al.
Nature Communications|March 25, 2023
Aiolos represses CD4<sup>+</sup> T cell cytotoxic programming via reciprocal regulation of T<sub>FH</sub> transcription factors and IL-2 sensitivityKaitlin A Read, Devin M Jones, Srijana Pokhrel, et al.
Cancer Immunology Research|May 3, 2024
Metabolic Reprogramming of Tumor-Associated Macrophages Using Glutamine Antagonist JHU083 Drives Tumor Immunity in Myeloid-Rich Prostate and Bladder CancersMonali Praharaj, Fan Shen, Alex J Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 21, 2008
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamideLeo Luznik, Paul V O'Donnell, Heather J Symons, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2020
Metabolic programs define dysfunctional immune responses in severe COVID-19 patientsElizabeth A Thompson, Katherine Cascino, Alvaro A Ordonez, et al.
Cell Reports|March 10, 2021
Metabolic programs define dysfunctional immune responses in severe COVID-19 patientsElizabeth A Thompson, Katherine Cascino, Alvaro A Ordonez, et al.
Pageof 82

Showing results (771-780 of 817) with videos related to

Sort By:
Pageof 82
The Journal of Clinical Investigation|April 24, 2020
Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cellsMin-Hee Oh, Im-Hong Sun, Liang Zhao, et al.
Nature|July 27, 2018
Functional aspects of meningeal lymphatics in ageing and Alzheimer's diseaseSandro Da Mesquita, Antoine Louveau, Andrea Vaccari, et al.
Nature|November 7, 2018
Publisher Correction: Functional aspects of meningeal lymphatics in ageing and Alzheimer's diseaseSandro Da Mesquita, Antoine Louveau, Andrea Vaccari, et al.
Nature|September 16, 2021
An engineered IL-2 partial agonist promotes CD8<sup>+</sup> T cell stemnessFei Mo, Zhiya Yu, Peng Li, et al.
Oncotarget|June 12, 2020
An exploratory study of metformin with or without rapamycin as maintenance therapy after induction chemotherapy in patients with metastatic pancreatic adenocarcinomaKatherine M Bever, Erkut H Borazanci, Elizabeth A Thompson, et al.
Nature Communications|March 25, 2023
Aiolos represses CD4<sup>+</sup> T cell cytotoxic programming via reciprocal regulation of T<sub>FH</sub> transcription factors and IL-2 sensitivityKaitlin A Read, Devin M Jones, Srijana Pokhrel, et al.
Cancer Immunology Research|May 3, 2024
Metabolic Reprogramming of Tumor-Associated Macrophages Using Glutamine Antagonist JHU083 Drives Tumor Immunity in Myeloid-Rich Prostate and Bladder CancersMonali Praharaj, Fan Shen, Alex J Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 21, 2008
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamideLeo Luznik, Paul V O'Donnell, Heather J Symons, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2020
Metabolic programs define dysfunctional immune responses in severe COVID-19 patientsElizabeth A Thompson, Katherine Cascino, Alvaro A Ordonez, et al.
Cell Reports|March 10, 2021
Metabolic programs define dysfunctional immune responses in severe COVID-19 patientsElizabeth A Thompson, Katherine Cascino, Alvaro A Ordonez, et al.
Pageof 82